Hybrid peptides having mixed substance P (NK1), Neurokinin A (NK2) and bradykinin (BK2) antagonist properties
Gespeichert in:
| Veröffentlicht in: | Immunopharmacology 1996-06, Vol.33 (1-3), p.194-197 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 197 |
|---|---|
| container_issue | 1-3 |
| container_start_page | 194 |
| container_title | Immunopharmacology |
| container_volume | 33 |
| creator | Srivastava, Ved P. Goodfellow, Val S. Zuzack, John S. Jones, Steve Francis, Mary Beckey, Virginia E. Whalley, Eric T. |
| description | |
| doi_str_mv | 10.1016/0162-3109(96)00038-0 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_78411349</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>0162310996000380</els_id><sourcerecordid>78411349</sourcerecordid><originalsourceid>FETCH-LOGICAL-c306t-8763077ef16d82a90982b387d7a21ba7b7512f59bc4a0f364ffa976d8fa490e53</originalsourceid><addsrcrecordid>eNp9kMtOwzAQRb0AQSn8AUheoVYiYOdle4NUKqCIqrCAteXEk2JoHthJRf8eR6lYshhZc--dGfkgdE7JNSU0vfEVBhElYiLSKSEk4gE5QKM_-RidOPfpjZiJ5AgdcZ6kNOYjVC52mTUaN9C0RoPDH2prqjUuzQ9o7LrMtarKAb_iyeqZTq_wCjpbf5nKVHjWa-EUq0rjzCq9G-TJ3SC2al1XxrW4sXUDtjXgTtFhoTYOzvbvGL0_3L_NF8Hy5fFpPlsGeUTSNuAsjQhjUNBU81AJIniYRZxppkKaKZaxhIZFIrI8VqSI0rgolGA-W6hYEEiiMboc9vrT3x24VpbG5bDZqArqzknGY0qjWPhgPARzWztnoZCNNaWyO0mJ7MnKHqHsEUrhm56sJH7sYr-_y0rQf0N7rN6_HXzwn9wasNLlBjxHbSzkrdS1-f_AL5bdh9c</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>78411349</pqid></control><display><type>article</type><title>Hybrid peptides having mixed substance P (NK1), Neurokinin A (NK2) and bradykinin (BK2) antagonist properties</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Srivastava, Ved P. ; Goodfellow, Val S. ; Zuzack, John S. ; Jones, Steve ; Francis, Mary ; Beckey, Virginia E. ; Whalley, Eric T.</creator><creatorcontrib>Srivastava, Ved P. ; Goodfellow, Val S. ; Zuzack, John S. ; Jones, Steve ; Francis, Mary ; Beckey, Virginia E. ; Whalley, Eric T.</creatorcontrib><identifier>ISSN: 0162-3109</identifier><identifier>DOI: 10.1016/0162-3109(96)00038-0</identifier><identifier>PMID: 8856148</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Animals ; Asthma ; Bradykinin - antagonists & inhibitors ; Bradykinin antagonist ; Bradykinin Receptor Antagonists ; Guinea Pigs ; Heterodimer ; Humans ; Ileum - drug effects ; In Vitro Techniques ; Molecular Structure ; Neurokinin A ; Neurokinin A - antagonists & inhibitors ; Neurokinin-1 Receptor Antagonists ; Oligopeptides - chemistry ; Oligopeptides - pharmacology ; Pulmonary Artery - drug effects ; Rabbits ; Receptor, Bradykinin B2 ; Receptors, Neurokinin-2 - antagonists & inhibitors ; Structure-Activity Relationship ; Substance P ; Substance P - antagonists & inhibitors</subject><ispartof>Immunopharmacology, 1996-06, Vol.33 (1-3), p.194-197</ispartof><rights>1996 Elsevier Science B.V.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c306t-8763077ef16d82a90982b387d7a21ba7b7512f59bc4a0f364ffa976d8fa490e53</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,781,785,27929,27930</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8856148$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Srivastava, Ved P.</creatorcontrib><creatorcontrib>Goodfellow, Val S.</creatorcontrib><creatorcontrib>Zuzack, John S.</creatorcontrib><creatorcontrib>Jones, Steve</creatorcontrib><creatorcontrib>Francis, Mary</creatorcontrib><creatorcontrib>Beckey, Virginia E.</creatorcontrib><creatorcontrib>Whalley, Eric T.</creatorcontrib><title>Hybrid peptides having mixed substance P (NK1), Neurokinin A (NK2) and bradykinin (BK2) antagonist properties</title><title>Immunopharmacology</title><addtitle>Immunopharmacology</addtitle><subject>Animals</subject><subject>Asthma</subject><subject>Bradykinin - antagonists & inhibitors</subject><subject>Bradykinin antagonist</subject><subject>Bradykinin Receptor Antagonists</subject><subject>Guinea Pigs</subject><subject>Heterodimer</subject><subject>Humans</subject><subject>Ileum - drug effects</subject><subject>In Vitro Techniques</subject><subject>Molecular Structure</subject><subject>Neurokinin A</subject><subject>Neurokinin A - antagonists & inhibitors</subject><subject>Neurokinin-1 Receptor Antagonists</subject><subject>Oligopeptides - chemistry</subject><subject>Oligopeptides - pharmacology</subject><subject>Pulmonary Artery - drug effects</subject><subject>Rabbits</subject><subject>Receptor, Bradykinin B2</subject><subject>Receptors, Neurokinin-2 - antagonists & inhibitors</subject><subject>Structure-Activity Relationship</subject><subject>Substance P</subject><subject>Substance P - antagonists & inhibitors</subject><issn>0162-3109</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1996</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kMtOwzAQRb0AQSn8AUheoVYiYOdle4NUKqCIqrCAteXEk2JoHthJRf8eR6lYshhZc--dGfkgdE7JNSU0vfEVBhElYiLSKSEk4gE5QKM_-RidOPfpjZiJ5AgdcZ6kNOYjVC52mTUaN9C0RoPDH2prqjUuzQ9o7LrMtarKAb_iyeqZTq_wCjpbf5nKVHjWa-EUq0rjzCq9G-TJ3SC2al1XxrW4sXUDtjXgTtFhoTYOzvbvGL0_3L_NF8Hy5fFpPlsGeUTSNuAsjQhjUNBU81AJIniYRZxppkKaKZaxhIZFIrI8VqSI0rgolGA-W6hYEEiiMboc9vrT3x24VpbG5bDZqArqzknGY0qjWPhgPARzWztnoZCNNaWyO0mJ7MnKHqHsEUrhm56sJH7sYr-_y0rQf0N7rN6_HXzwn9wasNLlBjxHbSzkrdS1-f_AL5bdh9c</recordid><startdate>19960601</startdate><enddate>19960601</enddate><creator>Srivastava, Ved P.</creator><creator>Goodfellow, Val S.</creator><creator>Zuzack, John S.</creator><creator>Jones, Steve</creator><creator>Francis, Mary</creator><creator>Beckey, Virginia E.</creator><creator>Whalley, Eric T.</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19960601</creationdate><title>Hybrid peptides having mixed substance P (NK1), Neurokinin A (NK2) and bradykinin (BK2) antagonist properties</title><author>Srivastava, Ved P. ; Goodfellow, Val S. ; Zuzack, John S. ; Jones, Steve ; Francis, Mary ; Beckey, Virginia E. ; Whalley, Eric T.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c306t-8763077ef16d82a90982b387d7a21ba7b7512f59bc4a0f364ffa976d8fa490e53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1996</creationdate><topic>Animals</topic><topic>Asthma</topic><topic>Bradykinin - antagonists & inhibitors</topic><topic>Bradykinin antagonist</topic><topic>Bradykinin Receptor Antagonists</topic><topic>Guinea Pigs</topic><topic>Heterodimer</topic><topic>Humans</topic><topic>Ileum - drug effects</topic><topic>In Vitro Techniques</topic><topic>Molecular Structure</topic><topic>Neurokinin A</topic><topic>Neurokinin A - antagonists & inhibitors</topic><topic>Neurokinin-1 Receptor Antagonists</topic><topic>Oligopeptides - chemistry</topic><topic>Oligopeptides - pharmacology</topic><topic>Pulmonary Artery - drug effects</topic><topic>Rabbits</topic><topic>Receptor, Bradykinin B2</topic><topic>Receptors, Neurokinin-2 - antagonists & inhibitors</topic><topic>Structure-Activity Relationship</topic><topic>Substance P</topic><topic>Substance P - antagonists & inhibitors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Srivastava, Ved P.</creatorcontrib><creatorcontrib>Goodfellow, Val S.</creatorcontrib><creatorcontrib>Zuzack, John S.</creatorcontrib><creatorcontrib>Jones, Steve</creatorcontrib><creatorcontrib>Francis, Mary</creatorcontrib><creatorcontrib>Beckey, Virginia E.</creatorcontrib><creatorcontrib>Whalley, Eric T.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Immunopharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Srivastava, Ved P.</au><au>Goodfellow, Val S.</au><au>Zuzack, John S.</au><au>Jones, Steve</au><au>Francis, Mary</au><au>Beckey, Virginia E.</au><au>Whalley, Eric T.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Hybrid peptides having mixed substance P (NK1), Neurokinin A (NK2) and bradykinin (BK2) antagonist properties</atitle><jtitle>Immunopharmacology</jtitle><addtitle>Immunopharmacology</addtitle><date>1996-06-01</date><risdate>1996</risdate><volume>33</volume><issue>1-3</issue><spage>194</spage><epage>197</epage><pages>194-197</pages><issn>0162-3109</issn><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>8856148</pmid><doi>10.1016/0162-3109(96)00038-0</doi><tpages>4</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0162-3109 |
| ispartof | Immunopharmacology, 1996-06, Vol.33 (1-3), p.194-197 |
| issn | 0162-3109 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_78411349 |
| source | MEDLINE; Alma/SFX Local Collection |
| subjects | Animals Asthma Bradykinin - antagonists & inhibitors Bradykinin antagonist Bradykinin Receptor Antagonists Guinea Pigs Heterodimer Humans Ileum - drug effects In Vitro Techniques Molecular Structure Neurokinin A Neurokinin A - antagonists & inhibitors Neurokinin-1 Receptor Antagonists Oligopeptides - chemistry Oligopeptides - pharmacology Pulmonary Artery - drug effects Rabbits Receptor, Bradykinin B2 Receptors, Neurokinin-2 - antagonists & inhibitors Structure-Activity Relationship Substance P Substance P - antagonists & inhibitors |
| title | Hybrid peptides having mixed substance P (NK1), Neurokinin A (NK2) and bradykinin (BK2) antagonist properties |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-14T01%3A07%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Hybrid%20peptides%20having%20mixed%20substance%20P%20(NK1),%20Neurokinin%20A%20(NK2)%20and%20bradykinin%20(BK2)%20antagonist%20properties&rft.jtitle=Immunopharmacology&rft.au=Srivastava,%20Ved%20P.&rft.date=1996-06-01&rft.volume=33&rft.issue=1-3&rft.spage=194&rft.epage=197&rft.pages=194-197&rft.issn=0162-3109&rft_id=info:doi/10.1016/0162-3109(96)00038-0&rft_dat=%3Cproquest_cross%3E78411349%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=78411349&rft_id=info:pmid/8856148&rft_els_id=0162310996000380&rfr_iscdi=true |